Abstract

Hypoxia is a strong signal for cell migration and invasion in cancer. The reversion-inducing cysteine-rich protein with Kazal motif (RECK), a tumor suppressor, inhibits cancer cell migration and invasion and is frequently silenced in aggressive tumor cells by histone deacetylases (HDAC). However, the effect of RECK silencing in several cancer cells in a hypoxic microenvironment has not been fully delineated. In this report, we investigated whether hypoxia suppressed RECK expression and used HDAC inhibitor (HDACI) inhibition to restore RECK expression to inhibit cancer cell migration and invasion. HDACIs, including trichostatin A (TSA), completely rescued RECK expression, which was suppressed by hypoxia, in the H-Ras-transformed human breast MCF10A and the HT1080 cell lines (human fibrosarcoma). TSA suppressed the activity of matrix metalloproteinase-2 (MMP-2) and MMP-9, induced by hypoxia, and significantly inhibited hypoxia-stimulated migration and invasion of both cancer cells. RECK overexpression significantly inhibited the migration and invasion of cancer cells induced by hypoxia. The hypoxic effect on the migration and invasion of cells was equivalent to the effect seen using the small interfering RNA (siRNA) of RECK under normoxia, suggesting an inhibitory role for RECK in hypoxic conditions. We also showed that siRNA silencing of HDAC1 suppressed hypoxia-induced RECK downregulation and inhibited the migration and invasion of cancer cells. In conclusion, the inhibition of HDAC successfully restored the expression of RECK under hypoxic conditions. This resulted in the inhibition of cancer cell migration and invasion through the repression of MMP-2 and MMP-9 activity.

Highlights

  • The reversion-inducing cysteine-rich protein with Kazal motifs (RECK) protein is the only known membrane-bound metalloproteinase (MMP) inhibitor [1]

  • To evaluate the potential contribution of histone deacetylases (HDAC) in the hypoxia-induced inhibition of reversion-inducing cysteinerich protein with Kazal motif (RECK) expression, we treated the cells with an HDAC inhibitor (HDACI) (TSA) for 24 hours

  • Treatment with trichostatin A (TSA) under hypoxic conditions restored RECK expression at the mRNA level, as determined by real-time quantitative reverse transcription–PCR (RT-PCR) in both cell lines (Fig. 1B)

Read more

Summary

Introduction

The reversion-inducing cysteine-rich protein with Kazal motifs (RECK) protein is the only known membrane-bound metalloproteinase (MMP) inhibitor [1]. RECK is a 110-kDa glycoprotein that is expressed in many normal tissues, but it is absent in transformed and tumor-derived cells. RECK-transfected HT1080 fibrosarcoma cells produced only low levels of proMMP-9 in the culture medium. Previous work has found that purified RECK binds to and inhibits MMP-9 [1]. RECK is a negative regulator of MMP-2 and MT1-MMP and decreases angiogenesis and tumor growth in vivo. Authors' Affiliation: School of Life Sciences and Biotechnology, College of Natural Sciences, Kyungpook National University, Daegu, Korea

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call